Pote Manasi S, Gacche Rajesh N
Tumor Biology Laboratory, Department of Biotechnology, Savitribai Phule Pune University, Pune 411 007, MS, India.
Tumor Biology Laboratory, Department of Biotechnology, Savitribai Phule Pune University, Pune 411 007, MS, India.
Drug Discov Today. 2023 May;28(5):103537. doi: 10.1016/j.drudis.2023.103537. Epub 2023 Feb 16.
Of the many multidrug resistance (MDR) mechanisms, the ATP binding cassette (ABC) transporters expelling drug molecules out of cells is a major culprit in limiting the efficacy of present-day anticancer drugs. The present review offers an updated information on structure, function, and regulatory mechanisms of major MDR related ABC transporters such as P-glycoprotein, MRP1, BCRP and effect of modulators on their functions. An attempt has been made to provide a focused information on different modulators of ABC transporters so as utilize them in clinical practice for amelioration of emerging MDR crisis in cancer treatment. Finally, the importance ABC transporters as therapeutic targets has been discussed in the light of future strategic planning for translating the ABC transporter inhibitors in clinical practice.
在众多多药耐药(MDR)机制中,将药物分子排出细胞的ATP结合盒(ABC)转运蛋白是限制当今抗癌药物疗效的主要原因。本综述提供了有关主要MDR相关ABC转运蛋白(如P-糖蛋白、MRP1、BCRP)的结构、功能和调节机制的最新信息,以及调节剂对其功能的影响。已尝试提供关于ABC转运蛋白不同调节剂的重点信息,以便在临床实践中利用它们来缓解癌症治疗中出现的MDR危机。最后,根据将ABC转运蛋白抑制剂转化为临床实践的未来战略规划,讨论了ABC转运蛋白作为治疗靶点的重要性。